Covid 19 Statement
Enduring Activity

Credit Designation

Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC, designates this live activity for a maximum of 20.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians' Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 20.5 Contact Hours.

Maintenance of Certification (MOC)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 20.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Acknowledgment of Commercial Support

This activity is supported by educational grants from Amgen, Inc.; AstraZeneca; Blueprint Medicines Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb; Daiichi Sankyo, Inc.; Jazz Pharmaceuticals; Novartis Pharmaceuticals Corporation; Pfizer Inc.; and Takeda Oncology.

21st Annual International Lung Cancer Congress®

21st Annual International Lung Cancer Congress®

July 23 - 25, 2020

Live Webcast

All times will be in Pacific Time


The 21st Annual International Lung Cancer Congress® will provide current, practical information on the management of lung cancer, as well as a look at the novel agents and strategies with the potential to shape the future of lung cancer therapy. Leading international and national experts will provide perspectives on how to apply the latest data on targeted agents, immunotherapy, surgery, and radiation oncology in the clinic. Cutting-edge lectures, panel discussions, multidisciplinary tumor boards, and interactive question-and-answer sessions will provide a unique opportunity for participants to engage with the faculty as they share their perspectives and personal experiences on the clinical challenges and ongoing controversies in lung cancer management.

Acknowledgment of Commercial Support

This activity is supported by educational grants from Amgen, Inc.; AstraZeneca; Blueprint Medicines Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb; Daiichi Sankyo, Inc.; Jazz Pharmaceuticals; Novartis Pharmaceuticals Corporation; Pfizer Inc.; and Takeda Oncology.

Target Audience

This educational activity is directed toward medical, surgical, and radiation oncologists interested in the treatment of patients with lung cancer. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers and other healthcare professionals interested in the treatment of lung cancer are also invited to attend.

Learning Objectives

  • Identify biomarkers and testing strategies to optimize selection of therapy in patients with lung cancer
  • Evaluate emerging evidence concerning the management of patients with non-metastatic lung cancer
  • Apply recent data sets on single-agent and combination immunotherapeutic approaches to care for patients with advanced thoracic malignancies
  • Assess recent clinical data on targeted and cytotoxic strategies for the management of patients with thoracic malignancies
  • Discuss optimal and personalized sequencing strategies utilizing clinical trial evidence, performance status, and tumor characteristics
  • Describe the current status of current clinical trials or approaches to address variances in care for patients with thoracic malignancies

Program Directors

David R. Gandara, MD
David R. Gandara, MD
Professor of Medicine Emeritus
Division of Hematology/Oncology
Director of Thoracic Oncology
Senior Advisor to the Director
UC Davis Comprehensive Cancer Center
Sacramento, CA
Roy S. Herbst, MD, PhD
Roy S. Herbst, MD, PhD
Ensign Professor of Medicine (Medical Oncology)
Professor of Pharmacology
Chief of Medical Oncology
Associate Director for Translational Research
Yale Cancer Center
Yale School of Medicine
New Haven, CT
Heather A. Wakelee
Heather A. Wakelee, MD
Professor of Medicine (Oncology)
Stanford University Medical Center
Stanford, CA


2 Ways to Register

  1. Online: Click here.
  2. Phone: Please call (888) 949-0045 or (609) 378-3701 (credit cards only).

Daily Conference Rates Available – Contact us for details

Physicians' Education Resource® - ILC20

2 Clarke Drive
Suite 110
Cranbury, NJ 08512

Daily conference rates are now available!

We are pleased to offer flexible options to ensure viewers are able to participate in this valuable 3-day live, interactive conference. Don’t miss out on the chance to gain expert insights on lung cancer from our renowned faculty.

To attend for one day only, use code ILCC20Daily at checkout.

Registration Fees

  Full price Day Rate
Physicians $169 $84.50
Fellows* $119 $59.50
Nurses, PAs, Other Health Care Professionals $99 $49.50
Industry** $399 N/A

*FELLOWS registration must be accompanied by a letter from your director/chair stating current fellowship for discount. Cannot be combined with other discounts/coupon codes.
**INDUSTRY is defined by PER® as any person employed by a for-profit organization, including biotech, financial, and pharmaceutical.

For registration assistance, please email, or call +1-(888)-949-0045 or +1-(609)-378-3701.

A cancellation fee of 25% will be assessed on refunds requested prior to May 23rd, 2020, and a 50% fee on refunds requested on May 24th, 2020 through June 24th, 2020. No refunds will be made after June 24th, 2020. There is no charge for substitution. Substitutions can only be applied to the same conference and only two substitutions will be honored.

In the event of a meeting cancellation, full refunds will be processed within 30 days of the cancellation date.

Physicians' Education Resource®, LLC fully complies with the legal requirements of the Americans with Disabilities Act (ADA) and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us in order to receive service. Please call +1-(609)-378-3701.

PER® reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited. This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting Continuing Education materials.

By attending a PER® conference, meeting or related activity ("Events"), all participants, attendees, exhibitors, sponsors, and guests ("you") create an agreement between you and PER® regarding the use and distribution of your image, including but not limited to your name, voice, and likeness ("Image"). By attending the Events, you acknowledge and agree that photographs, video, and/or audio recordings may be taken of you and you grant permission to PER® (and its agents) to utilize, in perpetuity, your Image in any electronic or print distribution, or by other means hereinafter created, both now and in the future, for any lawful purpose as determined by PER®.

Meeting information is accurate at the time of posting.

PER® complies with the Physician Payments Sunshine Act as part of the Affordable Care Act. Accordingly, we may be required to collect information on transfers of value provided to any covered recipient under the Act.


You must be logged in to PER to register for this meeting

Or Register for PER now

*Required Fields

Login Information

Registration Information

Professional Information


Calendar of Events
Filter By